Note 8 - Segment Information and Dissaggregated Revenue (Tables)

9 Months Ended

Mar. 31, 2019

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2019	$	11,913	$	1,875	$	13,788	$	1,995		$	68	$	63
	2018		9,333		879		10,212		1,363			55		42
Branded Proprietary Products	2019		14		3		17		7			-		-
	2018		-		9		9		(2	)		1		-
Other Nutraceutical Businesses	2019		283		-		283		92			1		-
	2018		351		3		354		108			1		-
Total Company	2019		12,210		1,878		14,088		2,093			69		63
	2018		9,684		891		10,575		1,469			57		42

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2019	$	31,066	$	4,330	$	35,396	$	4,323	$	199	$	350
	2018		26,314		3,661		29,975		3,094		184		244
Branded Proprietary Products	2019		133		22		155		49		-		-
	2018		181		30		211		95		3		13
Other Nutraceutical Businesses	2019		803		39		842		271		2		-
	2018		853		106		959		333		2		1
Total Company	2019		32,002		4,391		36,393		4,643		201		350
	2018		27,348		3,797		31,145		3,522		189		258

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	Total Assets as of
	March 31,		June 30,
	2019		2018
Contract Manufacturing	$	19,756	$	12,200
Branded Proprietary Products		585		543
Other Nutraceutical Businesses		1,880		1,825
Total Company	$	22,221	$	14,568